Mulpleta 3 mg/1
Lusutrombopag · TABLET, FILM COATED · SHIONOGI INC.
No Recall History
Plain English
Mulpleta is a tablet, film coated containing lusutrombopag at 3 mg/1, taken oral. Manufactured by SHIONOGI INC..
Key Facts
- Brand Name
- Mulpleta
- Generic Name
- Lusutrombopag
- NDC Code (Product)
59630-551- Manufacturer
- SHIONOGI INC.
- Strength
- 3 mg/1
- Dosage Form
- TABLET, FILM COATED
- Route
- ORAL
- Marketing Status
- Application #
- NDA210923
- Marketing Start
- 08/27/2018
Recall History
No Recall HistorySide Effects Reported to FDA
FDA FAERS database · These are reported events, not confirmed side effects
death3 reports
drug ineffective3 reports
nausea3 reports
ascites2 reports
diarrhoea2 reports
headache2 reports
hospitalisation2 reports
mesenteric vein thrombosis2 reports
pain2 reports
pancytopenia2 reports
Frequently Asked Questions
What is Mulpleta used for?
Mulpleta contains Lusutrombopag. It is a tablet, film coated taken oral. Consult your doctor for specific uses.
Is Mulpleta a controlled substance?
Mulpleta is not classified as a controlled substance by the DEA.
What is the generic name for Mulpleta?
The generic name for Mulpleta is Lusutrombopag. There are no other listed brand versions of Lusutrombopag.
What is the NDC code for Mulpleta 3 mg/1?
The NDC (National Drug Code) for Mulpleta 3 mg/1 is 59630-551, listed by SHIONOGI INC..
Other Mulpleta Dosages
Not medical advice. Always consult your doctor or pharmacist before making any medication decisions.
Data from openFDA · Public domain (CC0 1.0)